Global Health & Medicine -> 2021 Vol.3(No.5)
Editorial
Review
Regional progress towards hepatitis C elimination in the Western Pacific Region, 2015-2020
Global Health & Medicine. 2021; 3(5):253-261.
Epidemiology of viral hepatitis C: Road to elimination in Japan
Global Health & Medicine. 2021; 3(5):262-269.
Prevalence, diagnosis, and treatment of hepatitis C in Mainland China
Global Health & Medicine. 2021; 3(5):270-275.
Achieving WHO target of HCV control in Hong Kong: challenges and strategies
Global Health & Medicine. 2021; 3(5):276-282.
HCV elimination in Hong Kong – Non-government organisation (NGO) activities
Global Health & Medicine. 2021; 3(5):283-287.
Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea
Global Health & Medicine. 2021; 3(5):288-292.
Taiwan accelerates its efforts to eliminate hepatitis C
Global Health & Medicine. 2021; 3(5):293-300.
Nationwide awareness-raising program for viral hepatitis in Japan: the "Shitte kan-en" project
Global Health & Medicine. 2021; 3(5):301-307.
Testing, diagnosis of viral hepatitis, and the follow-up policy in Japan
Global Health & Medicine. 2021; 3(5):308-313.
Use of information and communication technology in the support of viral hepatitis patients in Japan
Global Health & Medicine. 2021; 3(5):314-320.
Treatment progress and expansion in Japan: From interferon to direct-acting antiviral
Global Health & Medicine. 2021; 3(5):321-334.
Seamless support from screening to anti-HCV treatment and HCC/ decompensated cirrhosis: Subsidy programs for HCV elimination
Global Health & Medicine. 2021; 3(5):335-342.
Hepatitis medical care coordinators: Comprehensive and seamless support for patients with hepatitis
Global Health & Medicine. 2021; 3(5):343-350.
